Chemoinformaics analysis of 1,3-DIMETHOXY-2-CARBOXYANTHRAQUINONE
| Molecular Weight | 312.277 | nRot | 3 |
| Heavy Atom Molecular Weight | 300.181 | nRig | 19 |
| Exact Molecular Weight | 312.063 | nRing | 3 |
| Solubility: LogS | -3.355 | nHRing | 0 |
| Solubility: LogP | 2.717 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 41.2035 |
| nHD | 1 | BPOL | 18.1145 |
| QED | 0.797 |
| Synth | 2.247 |
| Natural Product Likeliness | 0.895 |
| NR-PPAR-gamma | 0.732 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.571 |
| Pgp-sub | 0 |
| HIA | 0.027 |
| CACO-2 | -4.818 |
| MDCK | 0.0000148 |
| BBB | 0.139 |
| PPB | 0.864211 |
| VDSS | 0.42 |
| FU | 0.0332962 |
| CYP1A2-inh | 0.156 |
| CYP1A2-sub | 0.908 |
| CYP2c19-inh | 0.056 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.473 |
| CYP2c9-sub | 0.126 |
| CYP2d6-inh | 0.077 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.095 |
| CYP3a4-sub | 0.123 |
| CL | 1.442 |
| T12 | 0.206 |
| hERG | 0.065 |
| Ames | 0.439 |
| ROA | 0.483 |
| SkinSen | 0.06 |
| Carcinogencity | 0.456 |
| EI | 0.289 |
| Respiratory | 0.161 |
| NR-Aromatase | 0.018 |
| Antiviral | Yes |
| Prediction | 0.806767 |